|    Join     |    Donate    |   Store    |   About NAMS
Facebook TwitterYouTubeLinkedinRSS

CME Information

2020NAMS_VirtualAM_650x65 (002)

The North American Menopause Society (NAMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Outlined below, the 2020 NAMS Virtual Annual Meeting offers opportunities to earn 23.75 AMA PRA Category 1 Credit(s) or certificates of participation. Credit is available through September 1, 2021.

Other healthcare providers who participate in these activities will receive a certificate of participation. For nurses and other learners who need to report contact hours of pharmacotherapeutic education, NAMS has determined that these activities include a maximum of 9.25 hours of pharmacotherapeutic education.

 

ACCME


Menopause 101 Course

Building the Foundation

The North American Menopause Society (NAMS) designates this Other activity (blended Internet enduring recordings with Internet live Q&A sessions) for a maximum of 3.5 AMA PRA Category 1 Credit(s)Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 1.5 pharmacotherapeutic hours also are available.

Learning Objectives

By participating in this activity, attendees should be able to

  • Understand when and how to initiate treatment and know the appropriate dose, route, and formulations available
  • Become familiar with hormone contraception in older reproductive women and recognize when to transition to hormone therapy
  • Apply nonhormone management options for hot flashes
  • Assess sexual health and libido concerns and review the role of treatment options, including testosterone
  • Discuss with patients perimenopause and beyond and the issues surrounding cardiovascular disease, breast, and bone health

Acknowledgment of Support
This CME activity is supported in part by a grant from
Astellas Pharma Global Development, Inc.
Pharmavite LLC   



Pre-Meeting Symposium

Menopause Symptom Management in 2020: One Size Doesn’t Fit All 

The North American Menopause Society (NAMS) designates this Other activity (blended Internet enduring recordings with Internet live Q&A sessions) for a maximum of 4.0 AMA PRA Category 1 Credit(s)Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours also are available.

Learning Objectives

By participating in this activity, attendees should be able to

  • Understand the burden of menopause on vasomotor symptoms and genitourinary syndrome of menopause
  • Become familiar with the role of hormone therapy
  • Discuss with patients nonpharmacologic, new nonhormone, and hormone therapies for vasomotor symptoms
  • Recognize the role of compounded bioidentical hormone therapy
  • Identify and manage the symptoms of perimenopause
  • Assess and manage genitourinary syndrome of menopause



Annual Meeting

NAMS 2020: Reaching New Heights in Menopause Care

The North American Menopause Society (NAMS) designates this Other activity (blended Internet enduring recordings with Internet live Q&A sessions) for a maximum of 16.25 AMA PRA Category 1 Credit(s)Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other healthcare providers who participate in this activity will receive a certificate of participation. A maximum of 5.75 pharmacotherapeutic hours also are available.


These credits include 16.25 AMA PRA Category 1 Credit(s)™ for the Annual Meeting lectures, symposia, and abstract presentations.

Learning Objectives

By participating in this activity, attendees should be able to

  • Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause
  • Become familiar with the novel risk factors for cardiovascular disease in women
  • Understand the role of wellness in midlife women’s health
  • Review which hormones contribute to menopause and how 
  • Identify strategies to address weight loss and management
  • Manage sleep and anxiety and explore novel treatment options
  • Review the issues surrounding midlife cognition 
  • Recognize the importance of sexual and cardiovascular health at midlife and beyond
  • Define the special needs of women when menopause comes early
  • Discuss the new genitourinary syndrome of menopause, osteoporosis, female pattern hair loss, and androgen excess guidelines and understand how and when to apply them
  • Separate health from hype with regard to social media and menopause
  • Appreciate the role of childhood adversity on mood and cognition at menopause

Acknowledgment of Support
This CME activity is supported in part by a grant from
Hims, Inc.






Copyright© 2020 |  Home  |  Privacy Policy  |   Site Map |

 

30100 Chagrin Blvd, Suite 210 - Pepper Pike, OH 44124, USA
Telephone: 440/442-7550 - Fax: 440/442-2660  - Email: info@menopause.org
Email a Friend
close
Please enter a valid email address.
255 character limit
Your friend will receive an e-mail invitation to view this page, but we will not store or share this e-mail address with outside parties.

To submit the email please enter the sum of 5 + 6.